Cerevel Therapeutics Inc... (CERE)
NASDAQ: CERE
· Real-Time Price · USD
44.96
0.33 (0.74%)
At close: Jul 31, 2024, 10:00 PM
Cerevel Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -14.57 | -13.95 | -8.92 | -12.54 | -9.16 | -13.29 | -10.27 | -10.83 | -20.22 | -20.22 | -17.12 | -15.34 | -8.57 |
PEG Ratio | 3.69 | -0.57 | 2.81 | 2.10 | -0.68 | 0.92 | -0.78 | -0.26 | -2.7 | 2.90 | -7.19 | -3.07 | -0.26 |
PS Ratio | n/a | 897.78 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 13.62 | 10.99 | 12.60 | 14.24 | 8.85 | 9.46 | 7.13 | 8.66 | 9.93 | 8.25 | 6.75 | 11.11 | 5.14 |
P/FCF Ratio | -64.08 | -75.29 | -47.01 | -62.89 | -40.11 | -56.09 | -53.42 | -66.7 | -74.18 | -88.74 | -94.49 | -66.4 | -42.52 |
P/OCF Ratio | -64.23 | -75.99 | -47.34 | -64.57 | -40.25 | -56.38 | -53.53 | -68.01 | -76.59 | -90.54 | -97.05 | -71.61 | -47.97 |
OCF/S Ratio | n/a | -11.81 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.65 | 0.71 | 1.34 | 1.04 | 0.85 | 0.70 | 0.61 | 0.08 | 0.07 | 0.06 | 0.06 | 0.12 | 0.10 |
Quick Ratio | 10.12 | 10.92 | 8.77 | 11.53 | 13.41 | 12.51 | 16.51 | 9.40 | 15.40 | 13.61 | 21.92 | 11.34 | 10.24 |
Current Ratio | 10.22 | 10.92 | 8.72 | 11.47 | 13.35 | 12.48 | 16.64 | 9.52 | 15.67 | 13.59 | 21.92 | 11.34 | 10.24 |
Asset Turnover | n/a | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -53.79 | -52.73 | -42.1 | -36.68 | -15.46 | -18.02 | -73.92 | n/a | -245.86 | -541.93 | -4.19K | -5.05K | -3.37K |
Return on Equity | -0.23 | -0.2 | -0.35 | -0.28 | -0.24 | -0.18 | -0.17 | -0.2 | -0.12 | -0.1 | -0.1 | -0.18 | -0.15 |
Return on Assets | -0.12 | -0.11 | -0.12 | -0.11 | -0.11 | -0.09 | -0.1 | -0.15 | -0.1 | -0.09 | -0.08 | -0.14 | -0.12 |
Return on Invested Capital | -0.14 | -0.12 | -0.15 | -0.12 | -0.11 | -0.11 | -0.1 | -0.17 | -0.12 | -0.1 | -0.08 | -0.14 | -0.13 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | 0.82 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | -16.09 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | -16.07 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | -16.93 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | -16.74 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |